Literature DB >> 19056217

Preadmission hyperglycemia is an independent risk factor for in-hospital symptomatic pulmonary embolism after major orthopedic surgery.

Boris Mraovic1, Brian R Hipszer, Richard H Epstein, Edward C Pequignot, Javad Parvizi, Jeffery I Joseph.   

Abstract

We investigate whether preadmission hyperglycemia is a risk factor for developing in-hospital symptomatic pulmonary embolism after major orthopedic surgery. Medical records of patients undergoing total hip or total knee arthroplasty from January 2001 to April 2006 were reviewed. The incidence of PE was 1.47% (107/7282 patients). Multivariate analysis showed that preadmission blood glucose (BG) of at least 200 mg/dL independently increased the risk of pulmonary embolism by 3.19 times (P = .015), when compared with patients with BG of less than 110 mg/dL. Other significant risks factors were age (>or=70 years old), body mass index of more than 30 kg/m(2), and congestive heart failure. Total knee had 2.19 times (P = .002) more risk than total hip arthroplasty and bilateral procedure increased the risk by 2.13 times (P = .015). Sex, American Society of Anesthesiologists status, duration of surgery, malignancy, pulmonary disease, hypertension, diabetes mellitus, dyslipidemia, sleep apnea, and stroke were not found to be significant risk factors for pulmonary embolism. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2008        PMID: 19056217     DOI: 10.1016/j.arth.2008.10.002

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  25 in total

Review 1.  The adverse effects of diabetes on osteoarthritis: update on clinical evidence and molecular mechanisms.

Authors:  K B King; A K Rosenthal
Journal:  Osteoarthritis Cartilage       Date:  2015-03-30       Impact factor: 6.576

Review 2.  Measurement of Hyperglycemia and Impact on Health Outcomes in People With Cancer: Challenges and Opportunities.

Authors:  Susan Storey; Diane Von Ah; Marilyn J Hammer
Journal:  Oncol Nurs Forum       Date:  2017-07-01       Impact factor: 2.172

Review 3.  Perioperative Management of Diabetes Mellitus: Novel Approaches.

Authors:  Nadine E Palermo; Rajesh Garg
Journal:  Curr Diab Rep       Date:  2019-02-26       Impact factor: 4.810

4.  Analysis: New point-of-care blood glucose monitoring system for the hospital demonstrates satisfactory analytical accuracy using blood from critically ill patients--an important step toward improved blood glucose control in the hospital.

Authors:  Jeffrey I Joseph
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

5.  Multicenter Observational Study of the First-Generation Intravenous Blood Glucose Monitoring System in Hospitalized Patients.

Authors:  Grant V Bochicchio; Brian R Hipszer; Michelle F Magee; Richard M Bergenstal; Anthony P Furnary; Angela M Gulino; Michael J Higgins; Peter C Simpson; Jeffrey I Joseph
Journal:  J Diabetes Sci Technol       Date:  2015-06-01

Review 6.  Diabetes and its negative impact on outcomes in orthopaedic surgery.

Authors:  Dane K Wukich
Journal:  World J Orthop       Date:  2015-04-18

7.  Deep venous thrombosis and pulmonary embolism are uncommon in East Asian patients after total hip arthroplasty.

Authors:  Bun Jung Kang; Young-Kyun Lee; Hee Joong Kim; Yong-Chan Ha; Kyung-Hoi Koo
Journal:  Clin Orthop Relat Res       Date:  2011-07-12       Impact factor: 4.176

8.  Outcomes of shoulder arthroplasty in diabetic patients as assessed by peri-operative A1C.

Authors:  Joseph M Statz; Eric R Wagner; John W Sperling; Robert H Cofield
Journal:  Int Orthop       Date:  2018-03-18       Impact factor: 3.075

Review 9.  The Emory University Perioperative Algorithm for the Management of Hyperglycemia and Diabetes in Non-cardiac Surgery Patients.

Authors:  Elizabeth W Duggan; Matthew A Klopman; Arnold J Berry; Guillermo Umpierrez
Journal:  Curr Diab Rep       Date:  2016-03       Impact factor: 4.810

10.  Does venous thromboembolism affect rehabilitation after hip fracture surgery?

Authors:  Young-Kyun Lee; Yoon-Hee Choi; Yong-Chan Ha; Jae-Young Lim; Kyung-Hoi Koo
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.